22 results
Treatment Approach to Hodgkin's Lymphoma

By Matthew Ho, MD PhD @MatthewHoMD
With Credit: Dr Sunita Nasta and Dr
Svoboda Ref: NCCN guidelines ... Hodgkins #Lymphoma #oncology ... #Hematology #management ... #treatment #guideline
2021 ACR/VF Guidelines for Management of Giant Cell Arteritis (GCA)

#GiantCell #Arteritis #GCA #ACR2021 #Management #rheumatology #algorithm
2021 ACR/VF Guidelines ... for Management ... of Giant Cell Arteritis ... ) #GiantCell #Arteritis ... #rheumatology #
Rheumatoid Arthritis - ACR 2021 Guidelines
 - Low Disease Activity
 - Moderate to High Disease Activity
Rheumatoid Arthritis ... - ACR 2021 Guidelines ... #ACR2021 #Guidelines ... #management #treatment ... #rheumatology
Vasculitis Management - ACR/VF 2021 Guidelines for Treatment & Management
 • Giant Cell Arteritis (GCA)
 •
- ACR/VF 2021 Guidelines ... • Giant Cell Arteritis ... • Takayasu's arteritis ... Treatment #ACR2021 #Guidelines ... #algorithm #rheumatology
Giant Cell Arteritis (GCA) - Vasculitis Management Algorithm - ACR/VF 2021 Guidelines
 • Visual Symptoms/Loss or
Giant Cell Arteritis ... ) - Vasculitis Management ... - ACR/VF 2021 Guidelines ... GCA #Vasculitis #Management ... #algorithm #rheumatology
Myelodysplastic Syndrome (MD) - Diagnosis and Management Summary
myelo (marrow) -dys- (abnormal) -plastic (shape) = funny-shaped cells
Myelodysplastic Syndrome ... Diagnosis and Management ... Myelodysplastic #Syndrome ... #treatment #hematology ... #oncology
2021 ACR/VF Guidelines for Management of Takayasu Arteritis (TAK)

#Takayasu #Arteritis #TAK #ACR2021 #Management #rheumatology #algorithm #vasculitis
2021 ACR/VF Guidelines ... for Management ... of Takayasu Arteritis ... TAK) #Takayasu #Arteritis ... #rheumatology #
Behçet's Syndrome
Systemic disease associated with inflammation of multiple organs, small-vessel vasculitis and large-vessel vasculopathy
Epidemiology:
 • Young
Behçet's Syndrome ... SLE, Reactive arthritis ... SLE, Reactive Arthritis ... #diagnosis #management ... signs #symptoms #rheumatology
2019 EULAR recommendations for thrombosis in (Antiphospholipid Syndrome) APS
Venous Thrombosis - Arterial Thrombosis
INR Target
Duration
Recurrence

Dr. Laurent ARNAUD
Antiphospholipid Syndrome ... Antiphospholipid #Syndrome ... #APS #management ... #EULAR2019 #guidelines ... #rheumatology #
Patient risk stratification algorithm for the treatment of cancer-associated thrombosis.

Currently, edoxaban and rivaroxaban are the only
gastrointestinal; GFR ... Anticoagulation #Management ... #Hematology #Oncology